论文部分内容阅读
安可欣粉针剂其有效成份是关孢呋肟,用该药治疗下呼吸道感染,评价本品的临床疗效、抗菌效果及安全性。方法:24例病人,男18例,女6例;年龄18—76岁。采用安可欣3—6g/d静脉分2—3次滴注,7—14天为一疗程。结果:临床有效率96％,细菌清除率94％(15/16),无明显不良反应。其结果显示:除绿脓杆菌外,对常见的临床检出的革兰氏阴性菌和阳性菌大多数敏感。1996年2月～1997年6月,我们应用安可欣治疗下呼吸道感染24例。观其疗效。
Ankang injection of its active ingredient is Guanfufu oxime, the drug treatment of lower respiratory tract infection, evaluation of the clinical efficacy of this product, antibacterial effect and safety. Methods: 24 patients, 18 males and 6 females; aged 18-76 years old. 3-6g / d intravenous infusion of Amoxicillin 2-3 times, 7-14 days for a course of treatment. Results: The clinical effective rate was 96%, bacterial clearance rate was 94% (15/16), no obvious adverse reactions. The results showed that: in addition to Pseudomonas aeruginosa, the common clinical detection of Gram-negative bacteria and positive bacteria most sensitive. From February 1996 to June 1997, we applied Ankoxin to treat 24 cases of lower respiratory tract infection. View its efficacy.